The Pharmacists’ NHP Symposium: Integrative pain management The Pharmacists’ NHP Symposium: Natural health products and menopause The Pharmacists’ NHP Symposium: Update on NHP regulation in Canada The Pharmacists’ NHP Symposium: Vitamin D—The heart of the matter The Pharmacists’ NHP Symposium: What works and what doesn’t Januvia: approved for monotherapy Xeloda: expanded colorectal cancer indication B.C. Interim Agreement with government extended Frequent glucose self-monitoring not cost-effective in type 2 diabetes Vidaza for acute myeloid leukemia, myelodysplastic syndrome U.S. healthcare reform: Far from finished Rexall program attracts employers First Previous 1843 1844 1845 1846 1847 Next Last
